BTK and leukemia: Other Chinese researchers focused their attention on compounds able to inhibit BTK and PI3Kδ, which both play crucial roles in the progression of leukemia; authors synthesized dual BTK/PI3Kδ inhibitors with the benzofuro[3,2-b]pyridine-2(1H)-one scaffold as anticancer agents that are more potent comparedto single targeted therapies.